Research
Hormonal
The metabolic benefits of the multifaceted intervention, specifically reductions in fasting insulin and IL-6, occur rapidly, with the greatest decreases observed by week 6 of the 12-week program.
If you start this combined lifestyle program, expect significant improvements in insulin sensitivity and inflammation within the first 6 weeks, even if full fat loss continues until week 12.
GoodQualifiesHIGH confidence
The greatest decreases in fasting plasma insulin (P<0.05) and IL-6 (P<0.001) occurred by week 6 of the intervention.
Why this rating
Based on the same RCT data, with clear statistical significance for week 6 measurements.
Source
The effect of a lifestyle intervention on metabolic health in young women
Sarah L. Dunn et al. · Diabetes Metabolic Syndrome and Obesity · 2014
DOI 10.2147/dmso.s67845
rct · n=30Cited 27×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →